These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 9511716)
21. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units. Kurz H; Herbich K; Janata O; Sterniste W; Bauer K J Hosp Infect; 2008 Nov; 70(3):246-52. PubMed ID: 18799241 [TBL] [Abstract][Full Text] [Related]
22. Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group. Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S55-7; discussion S57. PubMed ID: 12671453 [TBL] [Abstract][Full Text] [Related]
23. News of the Academy of Neonatal Nursing. Neonatal Netw; 2018 Mar; 37(2):126-132. PubMed ID: 29615161 [No Abstract] [Full Text] [Related]
25. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants. Broughton S; Bhat R; Roberts A; Zuckerman M; Rafferty G; Greenough A Arch Dis Child; 2006 Jan; 91(1):26-30. PubMed ID: 16188957 [TBL] [Abstract][Full Text] [Related]
26. [Recommendations for the prevention of respiratory syncytial virus infections. Standards Committee of the Spanish Society of Neonatology. Board of Directors of the Spanish Society of Neonatology]. Carbonell Estrany X; Quero Jiménez J An Esp Pediatr; 2000 Apr; 52(4):372-4. PubMed ID: 11006170 [TBL] [Abstract][Full Text] [Related]
27. Prophylaxis against respiratory syncytial virus in high-risk infants: administration of immune globulin and epidemiological surveillance of infection. Handal G; Logvinoff MM; Zegarra N; Allen L; Jesurun A; Levin G; Thida A Tex Med; 2000 May; 96(5):58-61. PubMed ID: 10843015 [TBL] [Abstract][Full Text] [Related]
28. Nosocomial infection: a risk factor for a complicated course in children with respiratory syncytial virus infection--results from a prospective multicenter German surveillance study. Simon A; Müller A; Khurana K; Engelhart S; Exner M; Schildgen O; Eis-Hübinger AM; Kamin W; Schaible T; Wadas K; Ammann RA; Wilkesmann A; Int J Hyg Environ Health; 2008 Jul; 211(3-4):241-50. PubMed ID: 17869579 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada. Paes B; Cole M; Latchman A; Pinelli J Curr Med Res Opin; 2009 Sep; 25(9):2191-6. PubMed ID: 19604126 [TBL] [Abstract][Full Text] [Related]
30. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Singleton R; Dooley L; Bruden D; Raelson S; Butler JC Pediatr Infect Dis J; 2003 Jun; 22(6):540-5. PubMed ID: 12799511 [TBL] [Abstract][Full Text] [Related]
31. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Singleton RJ; Bruden D; Bulkow LR Pediatr Infect Dis J; 2007 Nov; 26(11 Suppl):S46-50. PubMed ID: 18090200 [TBL] [Abstract][Full Text] [Related]
32. Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Bont L; Kimpen JL Intensive Care Med; 2002 May; 28(5):616-21. PubMed ID: 12029411 [TBL] [Abstract][Full Text] [Related]
33. Primary care issues for the healthy premature infant. Kelly MM J Pediatr Health Care; 2006; 20(5):293-9. PubMed ID: 16962433 [TBL] [Abstract][Full Text] [Related]
34. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Leidy NK; Margolis MK; Marcin JP; Flynn JA; Frankel LR; Johnson S; Langkamp D; Simoes EA Pediatrics; 2005 Jun; 115(6):1536-46. PubMed ID: 15930214 [TBL] [Abstract][Full Text] [Related]
35. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age. Resch B; Pasnocht A; Gusenleitner W; Müller W J Infect; 2005 Jun; 50(5):397-403. PubMed ID: 15907547 [TBL] [Abstract][Full Text] [Related]
36. Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Carpenter TC; Stenmark KR Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S33-40. PubMed ID: 14730268 [TBL] [Abstract][Full Text] [Related]
38. Development and validation of a risk scoring tool to predict respiratory syncytial virus hospitalization in premature infants born at 33 through 35 completed weeks of gestation. Sampalis JS; Langley J; Carbonell-Estrany X; Paes B; O'Brien K; Allen U; Mitchell I; Aloy JF; Pedraz C; Michaliszyn AF Med Decis Making; 2008; 28(4):471-80. PubMed ID: 18556643 [TBL] [Abstract][Full Text] [Related]
39. [The value of RSV-prophylaxis: the shortage of data must not result in hasty decisions]. Hansen MV Lakartidningen; 2000 Mar; 97(11):1300-2. PubMed ID: 10771552 [No Abstract] [Full Text] [Related]